21
Participants
Start Date
October 14, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Substance P
The participants will receive a continuous intravenous infusion of 20 mL of substance P (1.5 pmol/kg/min) over 20 minutes.
Placebo
The participants will receive a continuous intravenous infusion of 20 mL of placebo (isotonic saline) over 20 minutes.
Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Glostrup Municipality
Danish Headache Center
OTHER